Liposomal amphotericin B-induced reversible ototoxicity in a patient with disseminated histoplasmosis

Indian J Pharmacol. 2021 Mar-Apr;53(2):157-159. doi: 10.4103/0253-7613.316948.

Abstract

Amphotericin B (AmB) is a polyene antifungal agent used widely for systemic fungal infections. Infusion-related side effects, nephrotoxicity, and dyselectrolytemia are well-known adverse effects with the use of this drug. Liposomal preparation of AmB has less adverse events. However, ototoxicity due to AmB is scarcely mentioned in the literature. We report a case of disseminated histoplasmosis who was treated with liposomal amphotericin B (LAmB) and developed hearing loss during the treatment, which recovered after discontinuing the drug. This is a rare adverse effect of LAmB and reported only once from India, to the best of our knowledge.

Keywords: Delhi; Liposomal amphotericin B; histoplasmosis; ototoxicity.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / adverse effects*
  • Antifungal Agents / adverse effects*
  • Histoplasmosis / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Ototoxicity / etiology*

Substances

  • Antifungal Agents
  • liposomal amphotericin B
  • Amphotericin B